Tewksbury, MA, United States of America

François Maltais

This inventor holds 1 USPTO granted patent and 4 EPO patents. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: François Maltais. Retrieved from https://idiyas.com/inventor/françois-maltais

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: François Maltais: Innovator in Pharmaceutical Inventions

Introduction

François Maltais is a notable inventor based in Tewksbury, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit specific pathways related to various diseases.

Latest Patents

Maltais holds a patent for "Inhibitors of C-MET and uses thereof." This invention relates to compounds that are useful as inhibitors of PI3K, specifically targeting PI3Kγ. The patent also includes pharmaceutically acceptable compositions that comprise these compounds and outlines methods for using these compositions in the treatment of various diseases, conditions, or disorders. He has 1 patent to his name.

Career Highlights

François Maltais is currently employed at Vertex Pharmaceuticals, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in the field has allowed him to contribute to advancements that may improve patient outcomes.

Collaborations

Throughout his career, Maltais has collaborated with notable colleagues, including Tiansheng Wang and Jeremy Green. These collaborations have fostered an environment of innovation and have led to the development of impactful pharmaceutical solutions.

Conclusion

François Maltais is a dedicated inventor whose work in pharmaceutical inventions has the potential to make a significant impact on healthcare. His contributions, particularly in the area of C-MET inhibitors, highlight the importance of innovation in treating complex diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…